Perampanel overdose in low body mass index patients with epilepsy: a case report and review of the literature
Abstract Background Perampanel (PER) is a novel antiepileptic drug (AED) which employs a completely different mechanism of action compared to existing medications. Overall, PER is considered to be safe up to a dose of 12 mg per day. When used to treat refractory and super-refractory status epileptic...
Main Authors: | Kanitpong Phabphal, Prut Koonalintip |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13256-021-02759-9 |
Similar Items
-
PERAMPANEL IN THE TREATMENT OF REFRACTORY EPILEPSY IN EVERYDAY CLINICAL PRACTICE IN ADOLESCENTS
by: S. G. Burd, et al.
Published: (2017-03-01) -
Perampanel in the treatment of drug-resistant epilepsy in children
by: M. Yu. Bobylova, et al.
Published: (2018-01-01) -
Optimal Use of Perampanel in Asian Patients with Epilepsy: Expert Opinion
by: Chinvarun Y, et al.
Published: (2021-07-01) -
Current role of perampanel in pediatric epilepsy
by: Paola De Liso, et al.
Published: (2017-06-01) -
Epilepsi : Perampanel som tilläggsbehandling vid farmakoresistent epilepsi
by: Wiking, Margie
Published: (2020)